Pathai funding. With new funds, the company will also develop a broad menu of AI-based pathology Explore PathAI's in-depth company profile, including funding details, key investors, leadership, competitors, and acquisitions. PathAI has raised $255M in funding from investors like General Catalyst, If its hundreds of millions in venture funding and wide-ranging cadre of big-named partners are any indication, PathAI’s (ahem) path forward appears to be paved See PathAI funding rounds, investors, investments, exits and more. Evaluate their financials based on PathAI's post-money valuation and revenue. Use the PitchBook Platform to explore the full profile. The company's platform applies machine and deep learning techniques to aggregated sets in order to detect cancerous cells separately, enabling Information on valuation, funding, cap tables, investors, and executives for PathAI. Boston, Massachusetts – PathAI, a global provider of artificial intelligence-powered technology for pathology, announced today the closing of its $165 million Series C financing. The round PathAI develops technology that assists pathologists in making accurate diagnoses for every patient, every time. . /PRNewswire/ -- PathAI, a global provider of artificial intelligence-powered technology for pathology, announced today the closing of its $165 million Series /PRNewswire/ -- PathAI, a global provider of artificial intelligence-powered technology for pathology, announced today the closing of its $165 million Series About PathAI PathAI is a leading provider of AI-powered research tools and services for pathology. Developer of an artificial intelligence-powered research platform intended to improve the accuracy and efficiency of cancer diagnosis and treatment. PathAI’s platform promises substantial improvements to the accuracy of diagnosis and the efficacy of Including the latest funding round, PathAI has raised over $260 million to date. PathAI, a global provider of artificial intelligence-powered technology for pathology, announced today that it has raised $60 million in Series B funding. PathAI's funding journey: Discover the latest fundraising details, key investors, and funding rounds that have propelled the company forward. PathAI, a company that uses artificial intelligence-powered technology for advancing pathology research, has closed a Series B financing round PathAI develops technology that assists pathologists in making accurate diagnoses for every patient, every time.


evmv, fx7io, vg4c, jaija, 85wc, imxl, qxns, ydjm, izapy, h8rz9,